House Committee Greenlights Safety Bill

Law360, New York (June 20, 2007, 12:00 AM EDT) -- The U.S. House of Representatives Energy and Commerce Committee unanimously approved a bill that would renew drug user fees, strengthen drug safety and would not change current law for pediatric market exclusivity—unlike a bill that passed the U.S. Senate.

After the 39-0 vote Thursday night, the drug user fee can now head to the full House, likely next month.

The legislation must be passed this session because the current bill regarding the fees pharmaceutical companies pay to get their drugs reviewed by the U.S. Food and...
To view the full article, register now.